In today’s challenging healthcare environment, providers can only afford 70%-75% of the medical devices that they have otherwise approved on the basis of clinical importance or need.  While the deferral of the remaining technologies may be a necessary response to providers’ capital constraints, the elimination of vital medical technologies puts providers at risk by reducing their ability to:

• Attract/retain physicians and their patients;
• Deliver the best patient outcomes;
• Succeed in a pay-for-performance environment; and
• Maintain a competitive position in their markets.

MedVentures offers leading healthcare providers a capital-free, off balance sheet way to access vital, outcome-enhancing technologies that will meet their clinical and financial requirements – with no minimum periodic payments or procedure volume commitments. Working with MedVentures, providers now have a way to address capital constraints while also improving the quality of patient care and generating additional revenues.

Learn more > About MedVentures

Latest News